Femasys Inc (FEMY)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $11.89M
Last updated: Nov 17, 2026 at 11:05 AM ET
Femasys Inc (FEMY) Competitors
The companies most similar to Femasys are Retractable Technologies (RVP), Milestone Scientific (MLSS) and Nephros (NEPH). By market cap, Femasys ranks 12th of the 13 companies on this page; Merit Medical Systems (MMSI) is the largest at $5.19B. The median P/E of the 3 companies with a P/E is 21.2x.
Peer Comparison
FEMY's ROIC of -40.0% is below the peer median of 7.0%, and its revenue growth of -18.9% is below the median of 7.9%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Femasys (FEMY) | $11.89M | N/A | 5.6x | 0.0% | -40.0% | -18.9% | 0.00% |
| Retractable Technologies Inc (RVP) | $16.76M | N/A | 0.4x | -9.9% | -31.4% | -31.1% | 0.00% |
| Milestone Scientific (MLSS) | $27.82M | N/A | 3.0x | -44.0% | N/A | 22.3% | 0.00% |
| Nephros Inc (NEPH) | $33.15M | 23.1x | 1.5x | 8.8% | 10.8% | 18.0% | 0.00% |
| Harvard Bioscience Inc (HBIO) | $42.94M | N/A | 0.5x | -13.2% | -10.2% | 7.8% | 0.00% |
| Merit Medical Systems Inc (MMSI) | $5.19B | 21.2x | 3.2x | 9.9% | 7.0% | 8.4% | 0.00% |
| Daxor Corporation (DXR) | $49.51M | N/A | 266.9x | 19861.0% | N/A | 25.5% | 0.00% |
| Dare Bioscience Inc (DARE) | $12.93M | N/A | 6.4x | 0.0% | N/A | 499.6% | 0.00% |
| FibroBiologics, Inc. Common Stock (FBLG) | $6.57M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Fractyl Health, Inc. Common Stock (GUTS) | $11.99M | N/A | N/A | 0.0% | -245.8% | -57.1% | 0.00% |
| Sanara Medtech Inc (SMTI) | $297.06M | N/A | 2.6x | -2.7% | 16.9% | 8.0% | 0.00% |
| Embecta Corp (EMBC) | $366.02M | 3.1x | 0.3x | 8.6% | 18.4% | -8.1% | 0.64% |
| TherapeuticsMD Inc (TXMD) | $21.64M | N/A | 5.6x | -6.6% | N/A | -8.7% | 0.00% |
| Peer median | $30.49M | 21.2x | 2.8x | 0.0% | 7.0% | 7.9% | 0.00% |
Similar Companies
These are the 12 companies most similar to Femasys, ranked by how closely their business, size, sector and industry match. The largest group, 8 of the 12, is in Medical Instruments & Supplies; the other 4 span 2 industries.
| Company | About | Peers |
|---|---|---|
| Retractable Technologies Inc (RVP)Medical Instruments & Supplies | Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other medical products for the healthcare industry in the United... | RVP competitors |
| Milestone Scientific (MLSS)Medical Instruments & Supplies | Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States, China... | MLSS competitors |
| Nephros Inc (NEPH)Medical Instruments & Supplies | Nephros, Inc., a commercial stage company, develops and sells water solutions to the medical and commercial markets in the United States. | NEPH competitors |
| Harvard Bioscience Inc (HBIO)Medical Instruments & Supplies | Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enable fundamental research, discovery... | HBIO competitors |
| Merit Medical Systems Inc (MMSI)Medical Instruments & Supplies | Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology... | MMSI competitors |
| Daxor Corporation (DXR)Medical Instruments & Supplies | Daxor Corporation, a medical device company, provides cryobank and biotechnology services in the United States. | |
| Dare Bioscience Inc (DARE)Biotechnology | Dar Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing women's health products in the United States. | DARE competitors |
| FibroBiologics, Inc. Common Stock (FBLG)Biotechnology | FibroBiologics, Inc. is an innovative biotechnology company dedicated to advancing regenerative medicine through its proprietary fibroblast cell technology... | FBLG competitors |
| Fractyl Health, Inc. Common Stock (GUTS)Biotechnology | Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. | GUTS competitors |
| Sanara Medtech Inc (SMTI)Medical Instruments & Supplies | Sanara MedTech Inc. develops, markets and distributes skin and wound care products to physicians, hospitals, clinics... | SMTI competitors |
| Embecta Corp (EMBC)Medical Instruments & Supplies | Embecta Corp (EMBC) is a leading medical technology company specializing in innovative insulin delivery systems aimed at enhancing diabetes management. | EMBC competitors |
| TherapeuticsMD Inc (TXMD)Drug Manufacturers - Specialty & Generic | TherapeuticsMD, Inc. is a women's healthcare company in the United States. The company is headquartered in Boca Raton, Florida. | TXMD competitors |
Frequently Asked Questions About FEMY
Who are Femasys' main competitors?
The companies most similar to Femasys include Retractable Technologies (RVP), Milestone Scientific (MLSS), Nephros (NEPH), Harvard Bioscience (HBIO) and Merit Medical Systems (MMSI), listed from the closest match.
Who is Femasys' biggest competitor?
Merit Medical Systems (MMSI) is the largest of the similar companies at $5.19B; Retractable Technologies (RVP) is the closest match by business profile, size, sector and industry.
How does FEMY stock compare with its competitors?
FEMY's P/S is 5.6x against a peer median of 2.8x; its net margin is 0.0% against a peer median of 0.0%.
Which of Femasys' competitors pays a higher dividend?
Femasys pays no dividend. Embecta (EMBC) has a higher forward dividend yield; Embecta (EMBC) has the highest at 0.64%.
Is Femasys bigger than its competitors?
No. Femasys is 12th by market cap among the 13 companies on this page; the largest is Merit Medical Systems (MMSI) at $5.19B.
FEMY pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors